stem cells « Science and Enterprise

University Lab Licenses Printed Kidney Tissue Process

By Alan, on February 8th, 2022%

A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure. . . . → Read More: University Lab Licenses Printed Kidney Tissue Process

Preclinical Test Advances Synthetic Bio ALS Treatment

By Alan, on December 15th, 2021%

A candidate treatment for amyotrophic lateral sclerosis or ALS made with synthetic genetic material is shown to improve motor function and survival in lab mice. . . . → Read More: Preclinical Test Advances Synthetic Bio ALS Treatment

Cell Therapy Start-Up Raises $6M in Seed Funds

By Alan, on November 19th, 2021%

A new company providing clinical development and commercialization for emerging cell therapies began operations and raised $6 million in seed funding. . . . → Read More: Cell Therapy Start-Up Raises $6M in Seed Funds

Cell Therapy Biotech Raises $75.5M in Venture Funds

By Alan, on November 4th, 2021%

A developer of off-the-shelf genetically engineered platelet cells to treat a range of diseases is raising $75.5 million in its second venture round. . . . → Read More: Cell Therapy Biotech Raises $75.5M in Venture Funds

Stem Cell Patch Shown to Repair Retinal Damage

By Alan, on October 29th, 2021%

Research with lab rats shows a transplanted tissue patch derived from stem cells repairs damaged retinas and helps restore visual functions. . . . → Read More: Stem Cell Patch Shown to Repair Retinal Damage

Off-the-Shelf Stem Cell Company Forms, Gains $72M

By Alan, on September 24th, 2021%

A new enterprise developing packaged blood-forming stem cells as therapies for a range of diseases began operations and raised $72 million in venture funds. . . . → Read More: Off-the-Shelf Stem Cell Company Forms, Gains $72M

Pharma, Biotech Partner on Off-the-Shelf Cell Therapies

By Alan, on July 30th, 2021%

A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells. . . . → Read More: Pharma, Biotech Partner on Off-the-Shelf Cell Therapies

FDA Clears Stem Cell Trial for Multiple Sclerosis

By Alan, on July 27th, 2021%

The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients to treat their cases of multiple sclerosis. . . . → Read More: FDA Clears Stem Cell Trial for Multiple Sclerosis

FDA Okays Trial of Donated Stem Cells for Parkinson’s

By Alan, on June 21st, 2021%

An organization studying stem cell therapies says it received FDA authorization for a clinical trial to test donated stem cells to treat Parkinson’s disease. . . . → Read More: FDA Okays Trial of Donated Stem Cells for Parkinson’s

Trial to Test Direct Crispr Blood Stem Cell Edits

By Alan, on March 31st, 2021%

A clinical trial is set to begin that tests a direct form of gene editing with Crispr to correct inherited malfunctioning genes causing sickle cell disease. . . . → Read More: Trial to Test Direct Crispr Blood Stem Cell Edits

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise